Clinical trials in Letterkenny

Clinical investigations focusing on hormone receptor-positive and HER2-negative breast cancer patients with node-positive disease. These trials aim to optimize treatment strategies by evaluating the necessity of chemotherapy based on specific genomic indicators.

• Personalized Treatment Approaches
• Endocrine Therapy Optimization
• Recurrence Risk Assessment

Research centers on determining the effectiveness of combining standard adjuvant endocrine therapy with chemotherapy, using genomic testing to guide treatment decisions.

Studies examining how genomic testing can inform treatment decisions for breast cancer patients. The research evaluates the relationship between recurrence scores and treatment outcomes to develop more precise therapeutic strategies.

• Biomarker-Based Treatment
• Treatment Response Prediction
• Survival Outcome Analysis

This research aims to identify optimal treatment thresholds and improve disease-free survival through personalized medicine approaches.

Clinical research exploring the selective use of chemotherapy in breast cancer treatment protocols. The studies focus on identifying patients who can safely avoid chemotherapy while maintaining optimal treatment outcomes.

• Treatment De-escalation
• Quality of Life Impact
• Risk-Adapted Therapy

These trials aim to refine treatment algorithms and reduce unnecessary therapy while maintaining therapeutic efficacy.